Open Access

Oxidative damage to macromolecules in the thyroid - experimental evidence

  • Małgorzata Karbownik-Lewińska1, 2Email author and
  • Agnieszka Kokoszko-Bilska1, 2
Thyroid Research20125:25

DOI: 10.1186/1756-6614-5-25

Received: 6 December 2012

Accepted: 10 December 2012

Published: 27 December 2012

Abstract

Whereas oxidative reactions occur in all tissues and organs, the thyroid gland constitutes such an organ, in which oxidative processes are indispensable for thyroid hormone synthesis. It is estimated that huge amount of reactive oxygen species, especially of hydrogen peroxide (H2O2), are produced in the thyroid under physiological conditions, justifying the statement that the thyroid gland is an organ of “oxidative nature”. Apart from H2O2, also other free radicals or reactive species, formed from iodine or tyrosine residues, participate in thyroid hormone synthesis. Under physiological conditions, there is a balance between generation and detoxification of free radicals. Effective protective mechanisms, comprising antioxidative molecules and the process of compartmentalization of potentially toxic molecules, must have been developed in the thyroid to maintain this balance. However, with additional oxidative abuse caused by exogenous or endogenous prooxidants (ionizing radiation being the most spectacular), increased damage to macromolecules occurs, potentially leading to different thyroid diseases, cancer included.

Keywords

The thyroid gland Thyroid hormone synthesis Oxidative stress Free radical Antioxidant Prooxidant Hydrogen peroxide Iron

Introduction

Reactive oxygen species (ROS) and free radicals participate in numerous metabolic processes. Under physiological conditions, there is a balance between the production and detoxification of ROS [1, 2]. However, any internal or external pathological factor may disrupt this balance, leading to conditions referred to as oxidative stress, playing a significant role in the pathogenesis of several diseases [1].

The most basic reaction of oxidative stress is Fenton reaction:
F e 2 + + H 2 O 2 F e 3 + + O H + O H
(1)

The most harmful free radical is hydroxyl radical (OH), which is produced during this reaction. Both substrates of Fenton reaction are normally present in cells and possess important physiological roles.

Iron is an essential element for normal metabolic processes, being a cofactor for many biological reactions. On the other hand, free ionic iron, as a potent generator of ROS, can enhance oxidative stress. It is known that increased iron stores in tissue result in cellular toxicity and are associated with increased risk of cellular damage, cancer initiation included [1, 3, 4].

Hydrogen peroxide (H2O2) is a form of ROS. All cells produce continuously low or moderate amounts of H2O2 under physiological conditions. This ROS is generated mainly by the intracellular family of NADPH oxidases (NOX). At concentrations higher than physiological, H2O2 enhances oxidative stress, leading to increased DNA oxidative damage and consequent mutagenesis [5, 6].

Bivalent iron (ferrous ion; Fe2+) and/or H2O2, which initiate Fenton reaction are frequently used to experimentally induce oxidative damage to macromolecules [714].

Whereas oxidative reactions occur in all tissues and organs, the thyroid gland constitutes such an organ, in which oxidative processes are indispensable for thyroid hormone synthesis. It is estimated that huge amount of ROS, especially of H2O2, are produced in the thyroid under physiological conditions, justifying the statement that the thyroid gland is an organ of “oxidative nature”.

Hydrogen peroxide is an essential factor for thyroid hormone biosynthesis. It is produced in the thyroid gland by two isoform enzymes, dual oxidase 1 (DUOX1) and 2 (DUOX2), belonging to NOX family, with the most convincing experimental evidence found for DUOX2 [15, 16]. Both DUOX enzymes are expressed in the apical plasma membrane of thyroid follicular cells (thyrocytes) [15, 16]. In turn, NOX4 playing also an important role in the synthesis of H2O2 in the thyroid, acts intracellulary [17]. Hydrogen peroxide acts as an electron acceptor at each step of thyroid hormone synthesis, namely at iodide oxidation and, next, at its organification, as well as at coupling reaction of iodotyrosines [18]. It is essential for activity of thyroperoxidase (TPO) – the key enzyme for thyroid hormone synthesis.

Thyroperoxidase is a heme-dependent protein, thus it contains iron atoms in its structure. Hydrogen peroxide participates in autocatalytic covalent heme binding to the apoprotein of TPO molecule, thereby stabilizing the activity of the enzyme [19]. Hydrogen peroxide availability is the rate-limiting step in thyroid hormone biosynthesis, although H2O2 is produced in large excess compared with the amount of iodide incorporated into proteins. This may be due to relatively high Michaelis-Menten constant of TPO for H2O2, which means that relatively high concentrations of H2O2, as a substrate, are required to properly activate the enzyme [20, 21]. Large quantities and membrane permeable nature of H2O2 can lead to its diffusion from the luminal side of the apical membrane back to the cell. Because iron is present in TPO and H2O2 is indispensable for TPO activity, the thyroid gland may be exposed – under certain conditions – to excessive amounts of either Fe2+ or H2O2, or both, creating favorable conditions for additional Fenton reaction and, consequently, oxidative damage.

Thyrotropin (TSH), the main secretory and growth stimulatory factor for the thyroid, is obviously involved in the production of H2O2 in that gland. The major meaning of that fact is that an increased production of H2O2, with subsequently enhanced formation of free radicals (especially OH), takes place in any conditions accompanied by the increased blood TSH concentration. Thus, TSH stimulation results in goitre formation and, under certain conditions, in thyroid cancer initiation via the mechanism of, at least in part, oxidative stress. In agreement with this, oxidative stress creates required conditions for thyroid cell proliferation [22, 23].

Apart from H2O2, numerous other reactive species are formed in the thyroid, such as, for example, nitric oxide (NO). Also particular elements of thyroid hormone synthesis pathway are partially confirmed to exist as free radicals or other reactive species, such as: tyrosine free radical (Tyr ), diiodotyrosyl residue radical (DIT), diiodotyrosyl residue radical in thyroglobulin (Tg-DIT), iodine radical (I), iodinium ion (I+), hypoiodous acid intermediate [IO- (IOH)], and ascorbate radical (Asc) [24].

Due to potential huge oxidative stress in the thyroid gland, effective protective mechanisms should have been developed. An antioxidative defence system in the thyroid gland comprises both antioxidative enzymes and free radical scavengers.

The presence of the following antioxidative enzymes in the thyroid gland has been documented: superoxide dismutase (SOD), glutathione (GSH) peroxidase (GSH-Px) and catalase (CAT) [25]. In turn, antioxidants such as α- and γ-tocopherols, coenzyme Q, and ascorbic acid have also been found in the thyroids of different species. Among antioxidants present in the thyroid, peroxiredoxins (Prxs) seem to be of a special value, as they are involved in the process of H2O2 elimination, when this oxygen species is formed in response to TSH, and they protect thyroid cells from H2O2-induced apoptosis [25, 26].

The results, obtained in humans and in animal models, suggest that oxidative damage in the thyroid, especially this associated with thyroid cancer, is accompanied by increased activities of antioxidative enzymes or increased production of antioxidants, what – probably – represents the defence mechanism [27].

Additionally, there is substantial scientific evidence that the thyroid gland has perfectly developed a kind of autoregulation in terms of keeping redox balance under physiological conditions. For example, thyroglobulin, a specific thyroid glycoprotein, which provides sites for iodide organification, negatively regulates different components of thyroid hormone synthesis, those related to oxidative stress included (e.g. [28, 29]).

Protective mechanisms against huge oxidative stress have been developed to protect not only the thyroid gland but also the whole organism. Specific anatomical feature of the thyroid gland, i.e. a monolayer of thyrocytes surrounding the thyroid colloid, does separate the colloid from the circulation, avoiding the leakage of ROS into the blood and thereafter to other tissues.

Oxidative damage induced by Fenton reaction substrates

Fenton reaction substrates (Fe2+ or/and H2O2) were used in porcine thyroid to induce oxidative damage to membrane lipids (lipid peroxidation, LPO), to nuclear DNA and to mitochondrial DNA (mtDNA).

We found in our earlier in vitro study that H2O2 is not indispensable to induce LPO via Fenton reaction in porcine ovary homogenates, which means that external Fe2+ reacted with endogenous H2O2 [13]. Therefore we expected that the use of only one Fenton reaction substrate would be sufficient to induce LPO via Fenton reaction also in the thyroid gland, especially that both, Fe2+/Fe3+ and H2O2 are required for thyroid hormone synthesis, thus being presumably in high concentrations in this gland. In opposite to our expectation, none of Fenton reaction substrates, used separately, increased LPO in the thyroid gland [30].

Expectedly when Fe2+ and H2O2 were used to-gether, LPO increased significantly, however without H2O2 concentration-dependent effect, but with clear Fe2+-dependent effect [30]. Thus, Fe2+ was found to be a stronger damaging factor to membrane lipids than H2O2, but it still required the presence of external H2O2 to reveal damaging effect. These unexpected results can be explained by the fact that the thyroid gland is specialized to compartmentalize H2O2, making it unavailable for any undesirable reactions. Such an explanation is supported by results mentioned above and showing that the increase of LPO occurring in the presence of both exogenous Fenton reaction substrates did not depend on the concentration of H2O2. In other words, the addition of small amounts of H2O2, resulting in its low concentrations such as 10-5 mM (the lowest concentration used in the above cited study), was sufficient, but still indispensable, to induce LPO in thyroid homogenates. It should be stressed that the lowest H2O2 concentration used in the study (10-5 mM) belongs to the range reached physiologically in cells – they vary from 0.001 μM to 15 μM [5, 31], however other than thyroid cells. Thus, not compartmentalized H2O2 concentration in the thyroid is possibly much lower than in other tissues, but that should be experimentally proved.

Interestingly, when we induced LPO by Fenton reaction in porcine thyroid homogenates [12] (in this earlier study we did not check concentration-dependent effect of Fenton reaction substrates), melatonin (N-acetyl-5-methoxytryptamine), being perfectly documented as an effective antioxidant [11, 3234], prevented LPO with the lowest effective concentration of 0.25 mM. At the same time melatonin did not affect the basal LPO [12], which supports the statement that this indoleamine is an excellent antioxidant.

When nuclear and mtDNA were exposed to Fenton reaction substrates, they appeared to be more sensitive than membrane lipids, i.e. 8-oxo-7,8-dihydro-2-deoxyguanosine (8-oxodG) concentration (DNA damage index) increased in the presence of only one Fenton reaction substrate [30, 35]. Again, Fe2+ appeared to be more stronger damaging factor to both, nuclear DNA [30] and mtDNA [35], than was H2O2. The most important observation concerning oxidative damage to nuclear DNA and mtDNA is that the background level of 8-oxodG in mtDNA [35] was approximately 10 times higher than that one in nuclear DNA [30]. This disproportion between mtDNA and nuclear DNA is in agreement with results found in other tissues [36, 37]. Concerning our observation on high mtDNA sensitivity to oxidative stress and the fact that thyroid oncocytic tumours are composed of cells filled – almost exclusively – with mitochondria characterized by molecular and enzymatic abnormalities, the following hypothesis can be formed. Whereas huge oxidative stress in the thyroid is hypothesized to play a crucial role in thyroid cancer, especially in papillary thyroid carcinoma, initiation [38], high oxidative damage to mtDNA in the thyroid allow to propose that oxidative processes substantially contribute to formation of thyroid tumors, with oxyphilic type of follicular thyroid carcinoma being of special significance [35].

In rat thyroid cell line (PCCl3), H2O2, used in concentrations 0.1-0.5 mM, caused a large number of DNA single-strand breaks and double-strand breaks. These data support the hypothesis that the generation of H2O2 in the thyroid could also play a role in mutagenesis, particularly in the case of antioxidant deficiency [39]. Additionally, these results [39] are in agreement with our findings [30, 35] showing, that the use of only one Fenton reaction substrate, in this case of H2O2, is sufficient to induce oxidative damage to DNA.

Oxidative damage induced by potassium bromate (KBrO3)

Potassium bromate (KBrO3) has been classified by International Agency for Research on Cancer (IARC) as a compound belonging to the group 2B of carcinogens (a possible human carcinogen) [40]. It has been demonstrated to cause, among others, follicular cell tumors in rat thyroid [41, 42]. In our in vivo model single injection of KBrO3 (110 mg/kg b.w., i.p.) expectedly induced LPO in the rat thyroid gland [43]. That prooxidative effect of KBrO3 was completely prevented by melatonin (0.0645 mmol/kg b.w., i.p., twice daily, for 10 days), but also by indole-3-propionic acid (IPA) (0.0645 mmol/kg b.w., i.p., twice daily, for 10 days) – an indole substance with chemical structure similar to melatonin, and also by propylthiouracil (PTU) (0.025% solution in drinking water, for 10 days) – an antithyroid drug possessing certain antioxidative properties [43].

In in vitro study KBrO3 induced – in concentration-dependent manner (for concentrations of 5 mM and 10 mM) – LPO in porcine thyroid homogenates [43]. However, LPO caused by KBrO3 (5 mM) was not prevented by melatonin, and also by the IPA. Only PTU (in concentrations of 5.0, 7.5 and 10.0 mM) significantly reduced KBrO3-induced LPO in homogenates of porcine thyroids [43].

The explanation of this apparent discrepancy (between in vivo and in vitro study) may be as following. First, the lack of protective effect of potential antioxidants in the in vitro conditions does not exclude their ability to reveal such an effect in living organisms; this observation has been confirmed for melatonin and IPA in the above mentioned study [43]. Second, molecules, like melatonin and IPA, act as endogenous electron donors, primarily detoxifying ROS; this mechanism may be responsible for the high efficacy of antioxidative action of melatonin and IPA in vivo. Because these indoles do not possess the redox-active hydroxyl group at position 5 of the indole ring, they do not act as chain-breaking antioxidants and, therefore, they are either poorly protective or not effective in vitro [44].

It should be also stressed, that the protective effects of PTU against KBrO3-induced LPO in the thyroid in vivo and in vitro only allow proceeding into details of the antioxidative mechanism of PTU action, but they do not allow recommending PTU for protection specifically against oxidative damage and against thyroid cancer.

Oxidative damage induced by nitrobenzene

Nitrobenzene is classified by IARC as possibly carcinogenic to humans (group 2B) [45]. It has been demonstrated, that nitrobenzene may induce thyroid follicular adenomas in mice, or both follicular thyroid adenomas and carcinomas in rats [46]. In our in vitro model nitrobenzene in concentrations of 7.5 and 10.0 mM induced LPO in porcine thyroid homogenates [Zasada and Karbownik-Lewińska, unpublished observations]. Nitrobenzene (7.5 mM) induced LPO was effectively prevented by melatonin, with its lowest effective concentration of 0.0001 mM. It should be stressed that this concentration of melatonin is only two orders of magnitude higher than physiological blood concentration in humans [Zasada and Karbownik-Lewińska, unpublished observations]. PTU also significantly reduced nitrobenzene-induced LPO, but only in its highest used concentration of 7.5 mM [Zasada and Karbownik-Lewińska, unpublished observations].

Oxidative damage caused by components of somatotrophic axis

The increased incidence of cancer of different kind [47], the presence of goiter and thyroid cancer [48, 49] in acromegalic patients and certain experimental evidence of growth hormone (GH) signalling effects on thyroid growth [50], and also potential cancerogenic properties of insulin-like growth factor I (IGF-I) justify to evaluate effects of somatotrophic axis components on oxidative damage to macromolecules, also in the thyroid.

In our in vitro study, GH, used in concentrations of 100, 10, 1.0, 0.01 μg/mL, and/or IGF-I, used in concentrations of 1000, 100, 10, 1.0, 0.1, 0.01, 0.001, 0.0001 μg/mL, did not change the basal LPO in porcine thyroid homogenates [51]. This effect was unexpected, but very desirable [51]. This finding may indicate that GH and IGF-I are very promising agents in terms of protection against oxidative damage under physiological conditions. At the same time, both GH and IGF-I significantly affected Fenton reaction-induced LPO. Namely, GH, in the lowest used concentrations (0.001 and 0.0001 μg/mL), prevented oxidative damage caused by Fenton reaction, thus revealing antioxidative effects; those effects of GH were the only protective effect against experimentally induced LPO, observed in this study. In other – higher (100, 10, 1.0, 0.1, 0.01 μg/mL) – used concentrations, we observed prooxidative effect of GH, i.e. GH enhanced Fenton reaction-induced LPO. In turn, IGF-I in all used concentrations enhanced Fenton reaction-induced LPO in porcine thyroid homogenates [51].

The fact that both GH and IGF-I may enhance oxidative damage initiated by other prooxidants does not support the idea that they may serve as protective factors under pathological conditions (other than GH deficiency).

Oxidative damage caused by deficiency of antioxidative components

The thyroid gland is characterized by relatively high level of selenium [25, 52]. Selenoproteins seem to be crucial for antioxidative protection in the thyroid, for thyroid hormone synthesis and for the global integrity of thyrocytes, as they are present in antioxidative enzymes such as GSH-Px, thioredoxin reductases, and also in deiodinases [25, 52]. When murine thyroids were experimentally depleted of selenoproteins at gene level, expectedly was found the increased oxidative damage to membrane lipids [evaluated by the increased 4-hydroxynonenal (4-HNE) level], and to proteins (evaluated by increased 3-nitro-tyrosine level) [53]. Although oxidative damage to DNA was not evaluated in this study, it is expected that this molecule in the thyroid is also damaged under conditions of selenium deficiency. The above results clearly suggest that under physiological conditions selenoproteins protect thyrocytes from oxidative damage to macromolecules.

Oxidative damage in thyroid cancer

The level of oxidative damage to macromolecules was found to be increased in cancerous thyroid tissue.

For example, in case of human thyroid diseases – non-toxic nodular goitre, carcinomas (follicular and papillary) and follicular adenoma – the highest level of LPO products was found in carcinomas; interestingly, it was also increased in follicular adenoma. Those changes were accompanied by increased activities of antioxidative enzymes, such as SOD, GSH-Px, and CAT, especially in case of thyroid carcinomas [54], and also in follicular thyroid adenomas and carcinomas [55].

In agreement with the above, increased levels of 8-oxodG and of 4-HNE were found not only in the cancerous tissues, such as follicular thyroid carcinoma and papillary thyroid carcinoma, but also in follicular thyroid adenoma [56]. Such findings [5456] suggest that oxidative damage to macromolecules may be an early event of thyroid cancer that may affect disease progression.

Whereas the level of antioxidative defence increases in differentiated thyroid cancer, a decreased expression of mRNA encoding for CAT and SOD were found in anaplastic thyroid carcinoma, when compared to histopathologically unchanged thyroid tissue and to differentiated thyroid tumors [57]. Thus, in case of advanced stages of thyroid diseases, like e.g. anaplastic carcinoma, the defence mechanisms remain inactive or depressed.

Conclusions

The increased oxidative damage to macromolecules in the thyroid occur in response to different exogenous prooxidants. The contribution of this oxidative damage to the development of thyroid diseases, cancer included, should be considered.

Abbreviations

Asc

Ascorbate radical

CAT: 

Catalase

DIT

Diiodotyrosyl residue radical

DUOX: 

Dual oxidase

Fe2+

Ferrous ion

GH: 

Growth hormone

GSH: 

Glutathione

GSH-Px: 

Glutathione peroxidase

4-HNE: 

4-hydroxynonenal

H2O2

Hydrogen peroxide

I

Iodine radical

I+

Iodinium ion

IARC: 

International Agency for Research on Cancer

IGF-I: 

Insulin-like growth factor I

[IO- (IOH)]: 

Hypoiodous acid intermediate

IPA: 

Indole-3-propionic acid

KBrO3

Potassium bromate

LPO: 

Lipid peroxidation

mtDNA: 

Mitochondrial DNA

NADPH: 

Nicotinamide adenine dinucleotide phosphate

NO

Nitric oxide

NOX: 

NADPH oxidase

8-oxodG: 

8-oxo-7,8-dihydro-2′-deoxyguanosine

OH: 

Hydroxyl radical

Prxs: 

Peroxiredoxins

PTU: 

Propylthiouracil

ROS: 

Reactive oxygen species

SOD: 

Superoxide dismutase

Tg-DIT

Diiodotyrosyl residue radical in thyroglobulin

TPO: 

Thyroperoxidase

TSH: 

Thyrotropin

Tyr

Tyrosine free radical.

Declarations

Authors’ Affiliations

(1)
Department of Oncological Endocrinology, Medical University of Lodz
(2)
Department of Endocrinology and Metabolic Diseases, Polish Mother’s Memorial Hospital – Research Institute

References

  1. Halliwell B: Free radicals and antioxidants: updating a personal view. Nutr Rev 2012, 70: 257–265. 10.1111/j.1753-4887.2012.00476.xView ArticleGoogle Scholar
  2. Ray PD, Huang BW, Tsuji Y: Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 2012, 24: 981–990. 10.1016/j.cellsig.2012.01.008PubMed CentralView ArticleGoogle Scholar
  3. Akhtar MJ, Kumar S, Murthy RC, Ashquin M, Khan MI, Patil G, Ahmad I: The primary role of iron-mediated lipid peroxidation in the differential cytotoxicity caused by two varieties of talc nanoparticles on A549 cells and lipid peroxidation inhibitory effect exerted by ascorbic acid. Toxicol In Vitro 2010, 24: 1139–1147. 10.1016/j.tiv.2010.03.002View ArticleGoogle Scholar
  4. Circu ML, Aw TY: Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 2010, 48: 749–762. 10.1016/j.freeradbiomed.2009.12.022PubMed CentralView ArticleGoogle Scholar
  5. Song Y, Driessens N, Costa M, De Deken X, Detours V, Corvilain B, Maenhaut C, Miot F, Van Sande J, Many MC, Dumont JE: Roles of hydrogen peroxide in thyroid physiology and disease. J Clin Endocrinol Metab 2007, 92: 3764–3773. 10.1210/jc.2007-0660View ArticleGoogle Scholar
  6. Braun J, Hüttelmaie S: Pathogenic mechanisms of deregulated microRNA expression in thyroid carcinomas of follicular origin. Thyroid Res 2011,4(Suppl 1):S1. 10.1186/1756-6614-4-S1-S1PubMed CentralView ArticleGoogle Scholar
  7. Cabrera J, Burkhardt S, Tan DX, Manchester LC, Karbownik M, Reiter RJ: Autoxidation and toxicant-induced oxidation of lipid and DNA in monkey liver: reduction of molecular damage by melatonin. Pharmacol Toxicol 2001, 89: 225–230. 10.1034/j.1600-0773.2001.d01-152.xView ArticleGoogle Scholar
  8. Gitto E, Tan DX, Reiter RJ, Karbownik M, Manchester LC, Cuzzocrea S, Fulia F, Barberi I: Individual and synergistic antioxidative actions of melatonin: studies with vitamin E, vitamin C, glutathione and desferrioxamine (desferoxamine) in rat liver homogenates. J Pharm Pharmacol 2001, 53: 1393–1401.View ArticleGoogle Scholar
  9. Karbownik M, Reiter RJ, Garcia JJ, Tan D: Melatonin reduces phenylhydrazine-induced oxidative damage to cellular membranes: evidence for the involvement of iron. Int J Biochem Cell Biol 2000, 32: 1045–1054. 10.1016/S1357-2725(00)00056-XView ArticleGoogle Scholar
  10. Karbownik M, Gitto E, Lewiński A, Reiter RJ: Relative efficacies of indole antioxidants in reducing autoxidation and iron-induced lipid peroxidation in hamster testes. J Cell Biochem 2001, 81: 693–699. 10.1002/jcb.1100View ArticleGoogle Scholar
  11. Karbownik M, Lewiński A, Reiter RJ: Anticarcinogenic actions of melatonin which involve antioxidative processes: Comparison with other antioxidants. Int J Biochem Cell Biol 2001, 33: 735–753. 10.1016/S1357-2725(01)00059-0View ArticleGoogle Scholar
  12. Karbownik M, Lewiński A: Melatonin reduces Fenton-induced lipid peroxidation in porcine thyroid tissue. J Cell Biochem 2003, 90: 806–811. 10.1002/jcb.10689View ArticleGoogle Scholar
  13. Karbownik-Lewińska M, Stępniak J, Krawczyk J, Zasada K, Szosland J, Gesing A, Lewiński A: External hydrogen peroxide is not indispensable for experimental induction of lipid peroxidation via Fenton reaction in porcine ovary homogenates. Neuro Endocrinol Lett 2010, 31: 343–347.Google Scholar
  14. Karbownik M, Reiter RJ, Burkhardt S, Gitto E, Tan DX, Lewiński A: Melatonin attenuates estradiol-induced oxidative damage to DNA: relevance for cancer prevention. Exp Biol Med (Maywood) 2001, 226: 707–712.Google Scholar
  15. Rigutto S, Hoste C, Grasberger H, Milenkovic M, Communi D, Dumont JE, Corvilain B, Miot F, De Deken X: Activation of dual oxidases Duox1 and Duox2: differential regulation mediated by camp-dependent protein kinase and protein kinase C-dependent phosphorylation. J Biol Chem 2009, 284: 6725–6734.PubMed CentralView ArticleGoogle Scholar
  16. Leto TL, Morand S, Hurt D, Ueyama T: Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases. Antioxid Redox Signal 2009, 11: 2607–2619. 10.1089/ars.2009.2637PubMed CentralView ArticleGoogle Scholar
  17. Weyemi U, Caillou B, Talbot M, Ameziane-El-Hassani R, Lacroix L, Lagent-Chevallier O, Al Ghuzlan A, Roos D, Bidart JM, Virion A, Schlumberger M, Dupuy C: Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in normal and cancer thyroid tissues. Endocr Relat Cancer 2010, 17: 27–37. 10.1677/ERC-09-0175View ArticleGoogle Scholar
  18. Karbownik M, Lewiński A: The role of oxidative stress in physiological and pathological processes in the thyroid gland; possible involvement in pineal-thyroid interactions. Neuro Endocrinol Lett 2003, 24: 293–303.Google Scholar
  19. Fayadat L, Niccoli-Sire P, Lanet J, Franc JL: Role of heme in intracellular trafficking of thyroperoxidase and involvement of H2O2 generated at the apical surface of thyroid cells in autocatalytic covalent heme binding. J Biol Chem 1999, 274: 10533–10538. 10.1074/jbc.274.15.10533View ArticleGoogle Scholar
  20. Hosoya T, Morrison M: The isolation and purification of thyroid peroxidase. J Biol Chem 1967, 242: 2828–2836.Google Scholar
  21. Corvilain B, Laurent E, Lecomte M, Van Sande J, Dumont JE: Role of the cyclic adenosine 3,5-monophosphate and the phosphatidylinositol-Ca2+ cascades in mediating the effects of thyrotropin and iodide on hormone synthesis and secretion in human thyroid slices. J Clin Endocrinol Metab 1994, 79: 152–159. 10.1210/jc.79.1.152Google Scholar
  22. Poncin S, Gérard AC, Boucquey M, Senou M, Calderon PB, Knoops B, Lengelé B, Many MC, Colin IM: Oxidative stress in the thyroid gland: from harmlessness to hazard depending on the iodine content. Endocrinology 2008, 149: 424–433.View ArticleGoogle Scholar
  23. Poncin S, Van Eeckoudt S, Humblet K, Colin IM, Gérard AC: Oxidative stress: a required condition for thyroid cell proliferation. Am J Pathol 2010, 176: 1355–1363. 10.2353/ajpath.2010.090682PubMed CentralView ArticleGoogle Scholar
  24. Taurog A: Hormone synthesis. In The Thyroid. Edited by: Braverman LE, Utiger RD. Philadelphia: Lippincott Williams & Wilkins; 2000:52–90.Google Scholar
  25. Köhrle J, Gärtner R: Selenium and thyroid. Best Pract Res Clin Endocrinol Metab 2009, 23: 815–827. 10.1016/j.beem.2009.08.002View ArticleGoogle Scholar
  26. Kovacic P, Edwards C: Integrated approach to the mechanisms of thyroid toxins: electron transfer, reactive oxygen species, oxidative stress, cell signaling, receptors, and antioxidants. J Recept Signal Transduct Res 2010, 30: 133–142. 10.3109/10799891003702678View ArticleGoogle Scholar
  27. Wang D, Feng JF, Zeng P, Yang YH, Luo J, Yang YW: Total oxidant/antioxidant status in sera of patients with thyroid cancers. Endocr Relat Cancer 2011, 18: 773–782. 10.1530/ERC-11-0230PubMed CentralView ArticleGoogle Scholar
  28. Suzuki K, Lavaroni S, Mori A, Ohta M, Saito J, Pietrarelli M, Singer DS, Kimura S, Katoh R, Kawaoi A, Kohn LD: Autoregulation of thyroid-specific gene transcription by thyroglobulin. Proc Natl Acad Sci USA 1998, 95: 8251–8256. 10.1073/pnas.95.14.8251PubMed CentralView ArticleGoogle Scholar
  29. Yoshihara A, Hara T, Kawashima A, Akama T, Tanigawa K, Wu H, Sue M, Ishido Y, Hiroi N, Ishii N, Yoshino G, Suzuki K: Regulation of dual oxidase expression and H2O2 production by thyroglobulin. Thyroid 2012, 22: 1054–1062. 10.1089/thy.2012.0003PubMed CentralView ArticleGoogle Scholar
  30. Stępniak J, Lewiński A, Karbownik-Lewińska M: Membrane lipids and nuclear DNA are differently susceptive to Fenton reaction substrates in porcine thyroid. Toxicol In Vitro 2013, 27: 71–78. 10.1016/j.tiv.2012.09.010View ArticleGoogle Scholar
  31. Schröder E, Eaton P: Hydrogen peroxide as an endogenous mediator and exogenous tool in cardiovascular research: issues and considerations. Curr Opin Pharmacol 2008, 8: 153–159. 10.1016/j.coph.2007.12.012View ArticleGoogle Scholar
  32. Galano A, Tan DX, Reiter RJ: Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011, 51: 1–16. 10.1111/j.1600-079X.2011.00916.xView ArticleGoogle Scholar
  33. Bonnefont-Rousselot D, Collin F: Melatonin: action as antioxidant and potential applications in human disease and aging. Toxicology 2010, 278: 55–67. 10.1016/j.tox.2010.04.008View ArticleGoogle Scholar
  34. Karbownik M, Reiter RJ: Antioxidative effects of melatonin in protection against cellular damage caused by ionizing radiation. Proc Soc Exp Biol Med 2000, 225: 9–22. 10.1046/j.1525-1373.2000.22502.xView ArticleGoogle Scholar
  35. Karbownik-Lewińska M, Stępniak J, Lewiński A: High level of oxidized nucleosides in thyroid mitochondrial DNA; damaging effects of Fenton reaction substrates. Thyroid Res in pressGoogle Scholar
  36. Richter C, Park JW, Ames BN: Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci USA 1988, 85: 6465–6467. 10.1073/pnas.85.17.6465PubMed CentralView ArticleGoogle Scholar
  37. Yakes FM, Van Houten B: Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA 1997, 94: 514–519. 10.1073/pnas.94.2.514PubMed CentralView ArticleGoogle Scholar
  38. Detours V, Delys L, Libert F, Weiss Solís D, Bogdanova T, Dumont JE, Franc B, Thomas G, Maenhaut C: Genome-wide gene expression profiling suggests distinct radiation susceptibilities in sporadic and post-Chernobyl papillary thyroid cancers. Br J Cancer 2007, 97: 818–825. 10.1038/sj.bjc.6603938PubMed CentralView ArticleGoogle Scholar
  39. Driessens N, Versteyhe S, Ghaddhab C, Burniat A, De Deken X, Van Sande J, Dumont JE, Miot F, Corvilain B: Hydrogen peroxide induces DNA single- and double-strand breaks in thyroid cells and is therefore a potential mutagen for this organ. Endocr Relat Cancer 2009, 16: 845–856. 10.1677/ERC-09-0020View ArticleGoogle Scholar
  40. IARC monographs on the evaluation of carcinogenic risks to humans: Potassium bromate. Lyon: IARC 1986, 40: 207–220.Google Scholar
  41. Kurokawa Y, Maekawa A, Takahashi M, Hayashi Y: Toxicity and carcinogenicity of potassium bromate - a new renal carcinogen. Environ Health Perspect 1990, 87: 309–335.PubMed CentralGoogle Scholar
  42. Wolf DC, Crosby LM, George MH, Kilburn SR, Moore TM, Miller RT, DeAngelo AB: Time- and dose-dependent development of potassium bromate-induced tumors in male Fischer 344 rats. Toxicol Pathol 1998, 26: 724–729. 10.1177/019262339802600602View ArticleGoogle Scholar
  43. Karbownik M, Stasiak M, Zasada K, Zygmunt A, Lewiński A: Comparison of potential protective effects of melatonin, indole-3-propionic acid and propylthiouracil against lipid peroxidation caused by potassium bromate in the thyroid gland. J Cell Biochem 2005, 95: 131–138. 10.1002/jcb.20404View ArticleGoogle Scholar
  44. Poeggeler B, Pappolla MA, Hardeland R, Rassoulpour A, Hodgkins PS, Guidetti P, Schwarcz R: Indole-3-propionate: a potent hydroxyl radical scavenger in rat brain. Brain Res 1999, 815: 382–388. 10.1016/S0006-8993(98)01027-0View ArticleGoogle Scholar
  45. IARC monographs on the evaluation of carcinogenic risks to humans: Nitrobenzene. Lyon: IARC 1996, 65: 381–408.Google Scholar
  46. Cattley RC, Everitt JI, Gross EA, Moss OR, Hamm TE Jr, Popp JA: Carcinogenicity and toxicity of inhaled nitrobenzene in B6C3F1 mice and F344 and CD rats. Fundam Appl Toxicol 1994, 22: 328–340. 10.1006/faat.1994.1039View ArticleGoogle Scholar
  47. Jenkins PJ, Mukherjee A, Shalet SM: Does growth hormone cause cancer? Clin Endocrinol (Oxf) 2006, 64: 115–121. 10.1111/j.1365-2265.2005.02404.xView ArticleGoogle Scholar
  48. Golkowski F, Krzentowska-Korek A, Baldys-Waligorska A, Hubalewska-Dydejczyk A: Goiter, cardiovascular and metabolic disorders in patients with acromegaly. Endocr Regul 2011, 45: 191–197. 10.4149/endo_2011_04_191View ArticleGoogle Scholar
  49. Dos Santos MC, Nascimento GC, Nascimento AG, Carvalho VC, Lopes MH, Montenegro R, Montenegro R Jr, Vilar L, Albano MF, Alves AR, Parente CV, Dos Santos Faria M: Thyroid cancer in patients with acromegaly: a case–control study. Pituitary in pressGoogle Scholar
  50. Gesing A, Bartke A, Masternak MM, Lewiński A, Karbownik-Lewińska M: Decreased thyroid follicle size in dwarf mice may suggest the role of growth hormone signaling in thyroid growth regulation. Thyroid Res 2012, 5: 7. 10.1186/1756-6614-5-7PubMed CentralView ArticleGoogle Scholar
  51. Kokoszko A, Dąbrowski J, Lewiński A, Karbownik-Lewińska M: Effects of growth hormone and insulin-like growth factor-I on the iron-induced lipid peroxidation in the rat liver and porcine thyroid homogenates. Neuro Endocrinol Lett 2010, 31: 517–523.Google Scholar
  52. Köhrle J, Jakob F, Contempré B, Dumont JE: Selenium, the thyroid, and the endocrine system. Endocr Rev 2005, 26: 944–984. 10.1210/er.2001-0034View ArticleGoogle Scholar
  53. Chiu-Ugalde J, Wirth EK, Klein MO, Sapin R, Fradejas-Villar N, Renko K, Schomburg L, Köhrle J, Schweizer U: Thyroid function is maintained despite increased oxidative stress in mice lacking selenoprotein biosynthesis in thyroid epithelial cells. Antioxid Redox Signal 2012, 17: 902–913. 10.1089/ars.2011.4055View ArticleGoogle Scholar
  54. Sadani GR, Nadkarni GD: Role of tissue antioxidant defence in thyroid cancers. Cancer Lett 1996, 109: 231–235. 10.1016/S0304-3835(96)04484-9View ArticleGoogle Scholar
  55. Yanagawa T, Ishikawa T, Ishii T, Tabuchi K, Iwasa S, Bannai S, Omura K, Suzuki H, Yoshida H: Peroxiredoxin I expression in human thyroid tumors. Cancer Lett 1999, 145: 127–132. 10.1016/S0304-3835(99)00243-8View ArticleGoogle Scholar
  56. Young O, Crotty T, O’Connell R, O’Sullivan J, Curran AJ: Levels of oxidative damage and lipid peroxidation in thyroid neoplasia. Head Neck 2010, 32: 750–756.Google Scholar
  57. Hasegawa Y, Takano T, Miyauchi A, Matsuzuka F, Yoshida H, Kuma K, Amino N: Decreased expression of catalase mRNA in thyroid anaplastic carcinoma. Jpn J Clin Oncol 2003, 33: 6–9. 10.1093/jjco/hyg009View ArticleGoogle Scholar

Copyright

© Karbownik-Lewinska and Kokoszko-Bilska; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement